info@trade-jp.net
menu
News / Blog
Delivery and Holidays in September
Catalog
| Product Code |
|
| Availability | Out Of Stock |
| Price | USD 15.00 |
| Qty |
Bromhexine hydrochloride tablets 4 mg - 100 tablets
Product Code :
Availability : Out Of Stock
USD 15.00
General information on Japanese Bromhexine hydrochloride tablets 4 mg for expectoration
Package details: 100 tablets
Manufacturer: Nichi-iko Pharmaceutical Co.,Ltd, Japan
Active ingredient: bromhexine hydrochloride (chemical formula C14H21Br2ClN2)
Medical effect: Bromhexine hydrochloride tablets are effective for the expectoration I the following cases:
- acute bronchitis,
- chronic bronchitis,
- bronchiectasis,
- pulmonary tuberculosis,
- pneumoconiosis
- after surgery condition.
Contraindications and precautions: do not use in pregnant or breastfeeding women. If an allergic reaction occurs, stop using the medication and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.
Dosage and administration of Japanese Bromhexine hydrochloride tablets 4 mg for expectoration
Adults should take 1 tablet 3 times a day. The dosage may be adjusted by the consulting doctor due to age and symptoms.
How effective are Bromhexine hydrochloride tablets 4 mg from Japan for expectoration?
Bromhexine hydrochloride was produced from Adhatoda vasica plant and broadly used in medicine since 1963. It promotes mucus secretion in lung and airway, thins and loosens mucus and enhances ciliary movement, by this, making expectoration easier. Bromhexine hydrochloride is effective for relieving coughs caused by the common cold, bronchitis, and various breathing illnesses.
Who should use Bromhexine hydrochloride tablets 4 mg from Japan?
The tablets of bromhexine hydrochloride are clinically proven to be safe in multiple studies performed all over the world (A. Zanasi, M. Mazzolini, A. Kantar. A reappraisal of the mucoactive activity and clinical efficacy of bromhexine // Multidisciplinary Respiratory Medicine, Volume 12, 2017. https://mrmjournal.biomedcentral.com/articles/10.1186/s40248-017-0088-1). They are recommended for patients with acute bronchitis, chronic bronchitis, bronchiectasis, pulmonary tuberculosis and pneumoconiosis.
